Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma

Published:2019-10 Issue:10 Volume:215 Page:152557
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Alafate Wahafu,Zuo Jie,Deng Zhong,Guo Xiaoye,Wu Wei,Zhang Wei,Xie Wanfu,Wang Maode,Wang Jia

Funder

National Natural Science Foundation of China

Fundamental Research Funds of Xi’an Jiaotong University

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference45 articles.

1. Epidemiology and etiology of gliomas;Ohgaki;Acta Neuropathol.,2005

2. Glioblastoma and chemoresistance to alkylating agents: involvement of apoptosis, autophagy, and unfolded protein response;Hombach-Klonisch;Pharmacol. Ther.,2018

3. The 2016 World Health Organization classification of tumors of the central nervous system: a summary;Louis;Acta Neuropathol.,2016

4. The effect of molecular diagnostics on the treatment of glioma;Bush;Curr. Oncol. Rep.,2017

5. Aurora kinases, aneuploidy and cancer, a coincidence or a real link?;Giet;Trends Cell Biol.,2005

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Identification of UBE2C As a Prognostic Biomarker and Correlated with Immunosuppression and Invasiveness in Glioma;2024-07-31

2. PCGF1 promotes the tumorigenesis of malignancies through upregulating CCDC34 in glioma;2024-06-12

3. UBE2C is associated with Prognosis of Immunosuppression and Cell Invasiveness in Glioma;2024-03-08

4. UBE2C enhances temozolomide resistance by regulating the expression of p53 to induce aerobic glycolysis in glioma;Acta Biochimica et Biophysica Sinica;2024-03-01

5. Systematic Identification of UBE2C As a Prognostic Biomarker and Correlated with Immunosuppression and Invasiveness in Glioma;2024-02-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3